Literature DB >> 9700209

Mutations in a novel gene, VMD2, encoding a protein of unknown properties cause juvenile-onset vitelliform macular dystrophy (Best's disease).

A Marquardt1, H Stöhr, L A Passmore, F Krämer, A Rivera, B H Weber.   

Abstract

Vitelliform macular dystrophy (Best's disease) is an autosomal dominant, early-onset form of macular degeneration in which the primary defect is thought to occur at the level of the retinal pigment epithelium. Genetic linkage has mapped the disease locus to chromosome 11q12-q13.1 within a 980 kb interval flanked by markers at loci D11S4076 and uteroglobin. To identify the disease gene, we systematically characterized genes from within the critical region and analysed the coding regions for mutations in 12 patients from large multigeneration Best's disease families. Following this approach, we identified a novel gene of unknown function carrying heterozygous mutations in all 12 probands. Of these, 10 result in distinct missense mutations of amino acids that are highly conserved throughout evolution, spanning a phylogenetic distance from Caenorhabditis elegans to human, and include V9M, A10T, W24C, R25Q, R218Q, Y227N, Y227C, V235M, P297A and F305S. One deletion mutation, DeltaI295, was found in two families and segregates with the disease in both cases. Northern blot analysis reveals tissue-specific expression for this gene, exclusively in the retinal pigment epithelium. In conclusion, our data provide strong evidence that mutations in the gene that we have identified cause Best's disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9700209     DOI: 10.1093/hmg/7.9.1517

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  123 in total

1.  Bestrophin, the product of the Best vitelliform macular dystrophy gene (VMD2), localizes to the basolateral plasma membrane of the retinal pigment epithelium.

Authors:  A D Marmorstein; L Y Marmorstein; M Rayborn; X Wang; J G Hollyfield; K Petrukhin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

Review 2.  Genetic factors of age-related macular degeneration.

Authors:  Jingsheng Tuo; Christine M Bojanowski; Chi-Chao Chan
Journal:  Prog Retin Eye Res       Date:  2004-03       Impact factor: 21.198

3.  Multimodal fundus imaging in Best vitelliform macular dystrophy.

Authors:  Daniela C Ferrara; Rogério A Costa; Stephen Tsang; Daniela Calucci; Rodrigo Jorge; K Bailey Freund
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-04-23       Impact factor: 3.117

Review 4.  Bestrophins and retinopathies.

Authors:  Qinghuan Xiao; H Criss Hartzell; Kuai Yu
Journal:  Pflugers Arch       Date:  2010-03-28       Impact factor: 3.657

Review 5.  [Morbus Best].

Authors:  O Strauss
Journal:  Ophthalmologe       Date:  2005-02       Impact factor: 1.059

6.  [Best's disease with normal EOG. Case report of familial macular dystrophy].

Authors:  K Pollack; F R Kreuz; L E Pillunat
Journal:  Ophthalmologe       Date:  2005-09       Impact factor: 1.059

Review 7.  Role of kidney chloride channels in health and disease.

Authors:  I Elias Veizis; Calvin U Cotton
Journal:  Pediatr Nephrol       Date:  2006-11-16       Impact factor: 3.714

8.  Bestrophin expression and function in the human pancreatic duct cell line, CFPAC-1.

Authors:  Laura L Marsey; John P Winpenny
Journal:  J Physiol       Date:  2009-02-23       Impact factor: 5.182

9.  Rescue of volume-regulated anion current by bestrophin mutants with altered charge selectivity.

Authors:  Li-Ting Chien; H Criss Hartzell
Journal:  J Gen Physiol       Date:  2008-11       Impact factor: 4.086

10.  Suppression of Ca2+ signaling in a mouse model of Best disease.

Authors:  Youwen Zhang; J Brett Stanton; Jiang Wu; Kuai Yu; H Criss Hartzell; Neal S Peachey; Lihua Y Marmorstein; Alan D Marmorstein
Journal:  Hum Mol Genet       Date:  2010-01-06       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.